Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Acknowledgement to reviewers98
Refining long-term surveillance requirements in patients with differentiated thyroid cancer77
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression59
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms58
Celebrating the 80th anniversary of hormone ablation for prostate cancer54
Acknowledgement to reviewers51
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs45
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients44
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas43
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications38
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing38
Prognostic of recurrence and survival in poorly differentiated thyroid cancer33
Update on the genetics of paragangliomas31
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells30
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells30
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas30
Targeting growth hormone in cancer: future perspectives30
Metabolically active brown adipose tissue in PPGL: an observational cohort study29
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts29
Radioiodine treatment: an historical and future perspective29
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells28
Peptide receptor radionuclide therapy in malignant insulinoma26
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation25
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet25
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation25
0.031332969665527